Edwards Lifesciences Corporation
EW
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspā¦ read more
Healthcare
Medical Devices
26 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$86.18
Price-0.62%
-$0.54
1Y
Price
Market Cap
$49.622b
Large
Price/Earnings 3y Avg5y Avg
31.9x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+29.8%
EBITDA Margin+13.9%
Net Profit Margin+33.6%
Free Cash Flow Margin+29.8%
EBITDA Margin+13.9%
Net Profit Margin+33.6%
Free Cash Flow MarginRevenue
$6.512b
+7.3%
1y CAGR+9.2%
3y CAGR+5.1%
5y CAGREarnings
$1.005b
-6.4%
1y CAGR+39.0%
3y CAGR+27.3%
5y CAGREPS
$1.74
-4.9%
1y CAGR+41.5%
3y CAGR+29.7%
5y CAGRBook Value
$10.725b
$13.867b
Assets$3.142b
Liabilities$704.400m
DebtDebt to Assets
5.1%
0.5x
Debt to EBITDAFree Cash Flow
$1.434b
+7.4%
1y CAGR+104.7%
3y CAGR+70.0%
5y CAGRNo items found.
Press Releases
Statements and updates from the company